List of works - Turid Aas

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

scientific article

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

scientific article published on 01 February 1997

Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status

scientific article published on 31 October 2009

Breast conserving surgery in breast cancer. Experiences from the Haukeland Hospital 1983-88

scientific article

Breast sarcoma. Diagnostic and therapeutic problems

scientific article published on 01 June 1989

Breast-preserving surgery in breast cancer. Experiences from Haukeland Hospital 1983-1988

scientific article published in January 1990

Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

scientific article

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

scientific article

Diet in women with breast cancer compared to healthy controls - What is the difference?

scientific article published on 24 November 2017

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer

scientific article

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

scientific article

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

scientific article

Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer

scientific article

Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls

scientific article published on 2 June 2016

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

scientific article (publication date: 11 September 2001)

Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer

article

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

scientific article

Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

scientific article

Increase of endo-peptidases and exo-peptidases in thyroid-tumors ⬇️

scientific article published on September 1, 1994

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer

scientific article published in March 2001

Jan Erik Varhaug

scientific article published on 19 February 2018

Lack of diagnostic-value of DNA content and p53 immunostaining in normal, hyperplastic and neoplastic parathyroid tissue.

scientific article

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

scientific article

Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer

scientific article

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

scientific article published on July 2001

Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel

scientific article

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

scientific article published in March 2003

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome

scientific article published on 01 January 1996

Progesterone binding cyst protein in hormone receptor positive breast cancer; a predictive factor for effect of adjuvant tamoxifen treatment

scientific article published on 01 September 1994

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin.

scientific article published in March 2005

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

scientific article published on September 2013

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

scientific article published on 01 July 1996

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

scientific article published on 22 June 2015

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer

scientific article

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy

scientific article

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.

scientific article published on 8 July 2009

Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival

scientific article published on 9 September 2016

[Primary treatment of locally advanced breast cancer with neoadjuvant chemotherapy]

scientific article published on 01 February 1994

List of works by Turid Aas

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status

Breast conserving surgery in breast cancer. Experiences from the Haukeland Hospital 1983-88

Breast sarcoma. Diagnostic and therapeutic problems

Breast-preserving surgery in breast cancer. Experiences from Haukeland Hospital 1983-1988

Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

Diet in women with breast cancer compared to healthy controls - What is the difference?

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer

Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

Increase of endo-peptidases and exo-peptidases in thyroid-tumors ⬇️

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer

Jan Erik Varhaug

Lack of diagnostic-value of DNA content and p53 immunostaining in normal, hyperplastic and neoplastic parathyroid tissue.

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome

Progesterone binding cyst protein in hormone receptor positive breast cancer; a predictive factor for effect of adjuvant tamoxifen treatment

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin.

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.

Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival

[Primary treatment of locally advanced breast cancer with neoadjuvant chemotherapy]